市場調查報告書
商品編碼
1276433
醫用輻射探測器全球市場規模、份額和行業趨勢分析報告:按產品、類型、最終用途、區域展望和預測,2023-2029 年Global Medical Radiation Detection Market Size, Share & Industry Trends Analysis Report By Product, By Type (Gas-filled Detectors, Scintillators and Solid-state), By End-Use, By Regional Outlook and Forecast, 2023 - 2029 |
預計到 2029 年,醫用輻射檢測儀市場規模將達到 15 億美元,預測期內復合年增長率為 7.7%。
隨著世界各地建造更多的核電站,對輻射監測技術的需求也越來越大。這些電廠產品類別可以應用於醫療保健領域。醫院還支持使用提供給患者的醫用同位素建造診斷成像設備。
來自人造輻射源的大部分人體劑量是由於診斷放射照相術以及在腫瘤學和其他重要疾病中使用放射性同位素進行的治療。此外,未來還計劃使用使用放射性元素的診斷和治療技術。放射(放射性同位素)療法仍然是用於治療癌症的主要方法之一。供應商提供用於個人劑量管理的個人劑量計和自動化系統,以減少輻射對醫療機構工作人員的有害影響。製造商和研究人員將創新技術融入到他們的產品中,以保持他們的市場領導地位。
COVID-19 影響分析
大流行改變了診斷成像測試的執行方式。許多醫療機構已實施新政策以降低 COVID-19 傳播的風險,例如採用便攜式 X 光機和減少掃瞄期間房間內的醫務人員數量。這些變化增加了對可在各種情況下使用的移動和手持式醫療輻射檢測工具的需求。考慮到這些因素,可以說醫用輻射檢測儀市場大大受益於 COVID-19 的傳播。
市場增長因素
全球癌症患者增加
近年來,各種癌症的治療、檢測和預防取得了顯著進展。手術、化學療法、放射療法、生物療法和激素療法用於治療癌症。阿黴素是一種常用的化療藥物,用於治療多種類型的腫瘤。氧化應激會影響腎臟、心臟和大腦。轉移性乳腺癌的化療耐藥性仍然是有效治療的一個問題。因此,這一因素推動了醫療輻射探測器市場。
擴大放射治療和核醫學的應用
設備、IT 和核醫學程序在過去十年中發生了巨大變化。使用核醫學診斷和治療癌症和心血管疾病等多種疾病增加了對輻射檢測、監測和安全系統的需求。核醫學中使用的檢測器有多種類型,包括充氣檢測器、閃爍檢測器和半導體檢測器。考慮到這些因素,放射治療和核醫學的使用增加預計將支持市場的擴大。
市場製約因素
嚴格的監管義務
核管理委員會(NRC)、美國國家輻射防護委員會(NCRP)、食品藥品監督管理局(FDA)、國際輻射防護委員會(ICRP)、美國能源部(DOE)等已建立輻射防護標準,認可此外,這些部門還制定了多項批准醫療輻射識別、監測和安全產品的協議。然而,這些嚴格的規定延長了產品批准過程。因此,嚴格的安全法規可能會延遲產品的推出和開發,預計會阻礙市場擴張。
按類型展望
醫用輻射探測器市場按類型分為充氣探測器、閃爍探測器和半導體探測器。到 2022 年,半導體部門在醫用輻射探測器市場中佔據相當大的收入份額。可以使用半導體檢測器檢測電離輻射。半導體檢測器非常有效,因為它們可以將很大一部分入射輻射轉換為電信號。因此,即使是非常低的輻射水平也可以被準確檢測到。例如,美國核管理委員會聲稱固態探測器在識別低能伽馬射線方面優於充氣探測器。
產品前景
按產品劃分,醫用輻射檢測器市場分為個人劑量計、過程劑量計、表面污染監測器等。到 2022 年,個人劑量計部分在醫用輻射檢測儀市場中佔據最大的收入份額。個人劑量計因其便攜性和易用性而變得越來越流行。在輻射暴露令人擔憂的地區工作的工人使用個人劑量計監測他們的暴露水平。
最終用途展望
醫用輻射探測器市場按最終用途細分為醫院、門診手術中心、診斷成像中心和家庭護理。2022 年醫用輻射檢測儀市場將佔醫院部分最大的收入份額。對 CT 掃瞄、X 射線和 PET 掃瞄等醫學成像的需求不斷增長。這是由於人口老齡化和慢性病的增加。醫用輻射探測器在這些任務中非常重要,可確保患者接受適量的輻射並防止過度暴露。
區域展望
按地區劃分,分析了北美、歐洲、亞太地區和 LAMEA 的醫用輻射探測器市場。到 2022 年,北美地區將以最高的收入份額引領醫用輻射檢測儀市場。這是由於人們越來越擔心在治療過程中暴露於電離輻射可能帶來的危險。因此,輻射安全越來越受到監管和醫療機構的關注。因此,越來越需要醫用輻射探測器來正確測量輻射水平並提高患者安全。
The Global Medical Radiation Detection Market size is expected to reach $1.5 billion by 2029, rising at a market growth of 7.7% CAGR during the forecast period.
A medical device that finds radiation is called a medical radiation detector. An individual is more likely to develop several lethal diseases when exposed to radiation over a long period. The need for technology that can gauge how much radiation is building up inside the body grows. The radiation portal monitor (RPM), handheld survey meter (HSM), personal radiation detector (PRD), and radiation isotope identification device (RIID) are a few of the important detectors for spotting radioactive materials and ionizing radiation.
As technology develops, a variety of radiation-detecting tools might be made accessible for use at home. Gamma rays are the most hazardous external radioactive threat, and dosimeters are medical radiation detectors that can find them. Radiation in various forms is utilized for both medical diagnosis and treatment. However, exposure must be carefully managed to ensure that the benefits to patients outweigh the hazards because all types have the potential to be hazardous.
Radiation monitoring technology is in greater demand as more nuclear power plants are built worldwide. These power plants' byproducts can be applied to the healthcare sector. Hospitals also support the building of diagnostic imaging equipment by using medicinal isotopes supplied to patients.
The majority of the dose a person receives from man-made radiation sources comes from X-ray diagnostics and therapies using radioisotopes in oncology and some other critical disorders. Additionally being used are the future radioactive element-based diagnostic and treatment techniques. Radiation (radioisotope) therapy is still one of the main methods used to treat cancer. Market vendors are supplying personal dosimeters and automated systems for personal dosage control to lessen the harmful effects of radiation on the staff of healthcare facilities. Manufacturers and researchers are incorporating innovative technology into their goods to maintain their position as market leaders.
COVID-19 Impact Analysis
The pandemic has changed how diagnostic imaging tests are carried out. Numerous healthcare facilities have implemented new policies to lower the danger of COVID-19 transmission, like adopting portable X-ray machines and reducing the number of healthcare staff in the room while imaging is done. These alterations have increased the demand for mobile and handheld medical radiation detection tools that can be applied in various circumstances. In light of these elements, the medical radiation detection market has significantly benefited from the widespread of COVID-19.
Market Growth Factors
Rising cases of cancer across the globe
The treatment, detection, and prevention of different cancers have made significant strides in recent years. Cancer is treated using surgery, chemotherapy, radiation, and biological and hormonal therapy. Doxorubicin is a frequently prescribed chemotherapy medication that is used to treat several tumor types. Oxidative stress has an impact on the kidney, heart, and brain. Chemotherapy drug resistance in metastatic breast cancer is still a problem for effective treatment. As a result, this element is fueling the medical radiation detection market.
Growing utilization of radiation therapy and nuclear medicine
Instrumentation, and IT, nuclear medicine procedures have drastically changed over the past ten years. The need for radiation detection, monitoring, and safety systems has increased due to the growing use of nuclear medicine in diagnosing and treating many diseases, including cancer and cardiovascular ailments. Gas-filled detectors, scintillation detectors, and semiconductor detectors are the different types used in nuclear medicine. In light of these factors, the growing usage of radiation therapy and nuclear medicine is predicted to support the market expansion.
Market Restraining Factors
Strict regulatory mandates
The Nuclear Regulatory Commission (NRC), National Council on Radiation Protection (NCRP), Food and Drug Administration (FDA), International Commission on Radiological Protection (ICRP), and the US Department of Energy (DOE) have established radiation protection standards that are recognized by the national authorities. In addition, these departments have established multiple protocols to approve medical radiation identification, monitoring, and safety products. Nevertheless, these rigorous regulations prolong the duration of the product approval procedure. Hence, with the strict safety regulations which can delay product launches and development are expected to hamper the market expansion.
Type Outlook
Based on type, the medical radiation detection market is characterized into gas-filled detectors, scintillators, and solid-state. The solid-state segment covered a considerable revenue share in the medical radiation detection market in 2022. Ionizing radiation can be found using solid-state detectors, which are quite effective since they can turn a significant part of incident radiation into an electrical signal. They can accurately detect radiation at very low levels due to this. For instance, the U.S. Nuclear Regulatory Commission asserts that solid-state detectors are superior to gas-filled detectors at identifying low-energy gamma rays.
Product Outlook
On the basis of product, the medical radiation detection market is classified into personal dosimeters, area process dosimeters, surface contamination monitors, and others. In 2022, the personal dosimeters segment witnessed the largest revenue share in the medical radiation detection market. Because of its qualities, including being portable and simple to use, personal dosimeters are growing in popularity. Workers working in areas where radiation exposure poses a concern have their exposure levels monitored by personal dosimeters.
End-Use Outlook
By end-use, the medical radiation detection market is divided into hospitals, ambulatory surgical centers, diagnostic imaging centers, and homecare. In 2022, the hospitals segment dominated the medical radiation detection market with the maximum revenue share. There is a rising need for medical imaging treatments like CT scans, X-rays, and PET scans. This is due to the growing elderly population and the rise in chronic diseases. Medical radiation detectors are crucial in these operations to ensure patients receive the proper dose of radiation and to guard against overexposure.
Regional Outlook
Region wise, the medical radiation detection market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the medical radiation detection market by generating the highest revenue share. This can be due to rising anxiety around the dangers that could be involved with being exposed to ionizing radiation during medical treatments. As a result, radiation safety is receiving increased attention from regulatory agencies and medical establishments. This has increased the need for medical radiation detectors to measure radiation levels correctly and improve patient safety.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBA Dosimetry GmbH, Mirion Technologies, Inc., Thermo Fisher Scientific, Inc., LANDAUER (Fortive Corporation), Polimaster Europe UAB, PTW Freiburg GmbH, ATOMTEX, Radiation Detection Company, MP Biomedicals, LLC (Valiant Co. Ltd), and Amray Group Ltd.
Strategies Deployed in Medical Radiation Detection Market
2023-Mar: Polimaster announced the launch of the new Polismart iOS app for iPhones and iPads. The launch aims to build a smarter way for the innovative operation of Polimaster products. The product is designed to offer users radiation exposure analytics and deeper insights.
2023-Feb: Mirion Technologies, Inc. collaborated with Flyability, a provider of Indoor drone solutions. Under this collaboration, the Mirion RDS-32 radiation survey meter would be combined with Flyability's Elios 3 indoor drone. This combination would allow nuclear operators to collect accurate radiation data remotely by drone, enabling nuclear personnel to stay safely outside of irradiated areas at the time of data collection.
2022-Sep: IBA S.A. collaborated with ScandiDos A.B., a technology company engaged in advanced Radiation Therapy Quality Assurance for radiation therapy dosimetry solutions. The alliance would allow the two businesses to operate together on product development, marketing, and product distribution in the specified markets for patient quality assurance for radiotherapy.
2022-May: IBA completed the acquisition of Modus Medical Devices Inc., a company specializing in phantoms for quality assurance for radiation therapy. This acquisition strengthens IBA's Dosimetry operations across North America and adds complete dosimetry 'phantom' suite on the market.
2021-Dec: Mirion Technologies, Inc. completed the acquisition of Computerized Imaging Reference Systems, Inc., a provider of medical imaging and radiation therapy phantoms serving the medical industry. The acquisition enhances patient outcomes and expands Mirion's Medical Segment.
2021-Nov: Mirion Technologies, Inc. took over CHP Dosimetry, a distributor of Dosimetry services. With this acquisition, Mirion would directly serve CHP Dosimetry's existing customers that would continue to utilize Mirion's strong dosimetry products.
2021-Oct: Mirion Technologies, Inc. acquired the Dosimetry Badge brand, a distributor of personal dosimeter badges. Following this acquisition, Mirion would strengthen its place in the US dosimetry market and serve existing Dosimetry Badge customers while offering them the choice to explore strong dosimetry options.
2021-Oct: IBA partnered with TRAD Tests & Radiations, a company offering a high level of service for all radiation testing, calculation, and analysis services. This partnership would allow the development of the latest radiation processing module based on TRAD's RayXpert 3D modeling and dose calculation technology.
2019-Mar: Thermo Fisher Scientific introduced Thermo Scientific Harshaw thermoluminescence dosimeter, a new dosimetry monitoring service. This launch allows medical and imaging facilities, laboratories, dental offices, and nuclear power plants. The products are created to allow facility operators to observe and track individual employees accumulated radiation dose with accuracy and precision.
Market Segments covered in the Report:
By Product
By Type
By End Use
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures